CHELATEXX

CHELATEXXCHELATEXXCHELATEXX

CHELATEXX

CHELATEXXCHELATEXXCHELATEXX
  • Home
  • Neuroassaults Links
  • Beagle Dog Study
  • CHELATEXX VIT-C
  • CHELATEXX for Autism
  • Reference Links
  • Preclinical Alzheimer's
  • Protocol to Treat
  • Time Sequential Actions

[Time Sequential OTC Drug Actions]

Envision a 3-hour TRAIN, where patients board the train at time zero, and the first stop is at 2.5 hours after embarking and and the last stop is 3-5 hours to disembark. 

  • Time 0- Ingestion of necessary dietary Proteins and Amino Acids with each meal. Dietary protein restriction causes growth retardation and is to be avoided.
  • Time 0- Ingest leafy green salad or cereal (Bran Buds)(Shredded Wheat) or comparable dietary means  
  • Time 0- Ingestion of CHELATEXX two 320 mg enteric coated capsules (or three capsules determined from the NIH/NIA funded Clinical Study by PPD   PPD.com) with each meal
  • Time 0- Ingestion of CHELATEXX VIT-C 250 mg capsule with each meal
  • Time 0 + 30 minutes CHELATEXX VIT-C dissolves in the stomach and transits the small intestines
  • Time 0+2.5 hours after ingestion, CHELATEXX VIT-C (ascorbic acid) is absorbed by active facilitated diffusion in the last, distal 10 cm of the small bowel (intestines) to prevent Vit C deficiency
  • Time 0+3 hours after ingestion, CHELATEXX VIT-C excess VIT-C (ascorbic acid) is advanced to the proximal colon to acidify the colon to pH of 5 to prevent neurotoxic ammonia systemic absorption from the colon,( for 3-5 hours). Castell and Moore reference.
  • Time 0+3 hours after ingestion, enteric coating of the USP 1600 AC dissolves releasing the USP 1600 AC into the proximal colon (large intestines) to absorb about 50% (proprietary Beagle Dog Study proof) of the neurotoxic ammonia for 3 to 5 hours after ingestion  (this reduces the neurotoxic ammonia from 68.8 micrograms/dl (Fisman reference) to below 40 micrograms/dl.


Castell and Moore reference  "Ammonia absorption from the human colon"  gastrojournal.org/articla/S0016-5085(71)80004-5/pdf

FIG #5 Percentage of colonic absorption of ammonia for each of 4 subjects

#1     20% at pH 5     40% at pH 9
#2     20% at pH 5     40% at pH 9
#3     30% at pH 5     50% at pH 9
# 4    50% at pH 5     70%at pH 9


Proprietary and Private Beagle Dog Study reference

Oral AST-120 Activated Charcoal decreased serum ammonia by 39% in one Beagle Dog

Oral AST-120 Activated Charcoal decreased serum ammonia by 49% in the second Beagle Dog

Fisman reference "Hyperammonemia in Alzheimer's disease"  www.pubmed.gov/3966587

Alzheimer's disease patients             68.8 micrograms/dl of blood ammonia
Hospital control patients                    44.8 micrograms/dl of blood ammonia
Community control patients               46.2 micrograms/dl of blood ammonia

Copyright © 2025 Chelatexx - All Rights Reserved.

  • Privacy Policy
  • Terms and Conditions

Powered by

This website uses cookies.

We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.

Accept